Michael Ryskin

Stock Analyst at B of A Securities

(1.43)
# 3,306
Out of 4,873 analysts
35
Total ratings
47.83%
Success rate
-2.31%
Average return

Stocks Rated by Michael Ryskin

Tempus AI
May 20, 2025
Maintains: Neutral
Price Target: $48$68
Current: $68.28
Upside: -0.41%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9$8
Current: $2.23
Upside: +258.74%
IDEXX Laboratories
Feb 4, 2025
Maintains: Neutral
Price Target: $475$535
Current: $530.50
Upside: +0.85%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200$206
Current: $186.58
Upside: +10.41%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28$40
Current: $49.99
Upside: -19.98%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10$9.5
Current: $5.50
Upside: +72.73%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27$24
Current: $10.69
Upside: +124.51%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27$24
Current: $13.46
Upside: +78.31%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225$180
Current: $157.77
Upside: +14.09%
Recursion Pharmaceuticals
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $5.22
Upside: -
Downgrades: Neutral
Price Target: $80$52
Current: $20.60
Upside: +152.43%
Downgrades: Underperform
Price Target: $17$10
Current: $2.81
Upside: +255.87%